Charles Schwab Investment Management Inc. increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,234,223 shares of the company's stock after purchasing an additional 107,162 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.33% of Acadia Healthcare worth $48,937,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Nisa Investment Advisors LLC boosted its position in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares during the last quarter. Atria Investments Inc boosted its holdings in Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company's stock valued at $434,000 after acquiring an additional 308 shares during the last quarter. Pacer Advisors Inc. increased its position in Acadia Healthcare by 2.4% in the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after purchasing an additional 325 shares during the period. KBC Group NV lifted its position in Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock valued at $170,000 after purchasing an additional 338 shares during the period. Finally, Tidal Investments LLC boosted its stake in shares of Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after purchasing an additional 340 shares during the last quarter.
Acadia Healthcare Stock Up 3.1 %
NASDAQ ACHC traded up $0.89 on Monday, reaching $29.43. The company had a trading volume of 1,192,420 shares, compared to its average volume of 1,315,404. The company's fifty day moving average is $40.15 and its 200-day moving average is $48.31. Acadia Healthcare Company, Inc. has a 1-year low of $27.61 and a 1-year high of $82.41. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of 9.65, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. StockNews.com downgraded shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Bank of America reduced their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. TD Cowen reduced their target price on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada lowered their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Finally, KeyCorp reduced their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research note on Monday, March 3rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of "Hold" and a consensus price target of $56.31.
Check Out Our Latest Report on Acadia Healthcare
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.